Search

Kevin E. Weddington

Examiner (ID: 6966)

Most Active Art Unit
1614
Art Unit(s)
1614, 1205, 1629, 2899
Total Applications
3386
Issued Applications
2180
Pending Applications
434
Abandoned Applications
815

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8164870 [patent_doc_number] => 08173709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Anti-infective methods for treating pathogen-induced disordered tissues' [patent_app_type] => utility [patent_app_number] => 10/816571 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 28374 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173709.pdf [firstpage_image] =>[orig_patent_app_number] => 10816571 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/816571
Anti-infective methods for treating pathogen-induced disordered tissues Mar 31, 2004 Issued
Array ( [id] => 7018849 [patent_doc_number] => 20050220868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Policosanol composition and its use in treatment of hypercholesterolemia' [patent_app_type] => utility [patent_app_number] => 10/813017 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1792 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220868.pdf [firstpage_image] =>[orig_patent_app_number] => 10813017 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/813017
Policosanol composition and its use in treatment of hypercholesterolemia Mar 30, 2004 Abandoned
Array ( [id] => 7466568 [patent_doc_number] => 20040198740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2' [patent_app_type] => new [patent_app_number] => 10/810880 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27918 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198740.pdf [firstpage_image] =>[orig_patent_app_number] => 10810880 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810880
Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 Mar 24, 2004 Abandoned
Array ( [id] => 4537198 [patent_doc_number] => 07875282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury' [patent_app_type] => utility [patent_app_number] => 10/805736 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 71 [patent_no_of_words] => 50326 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875282.pdf [firstpage_image] =>[orig_patent_app_number] => 10805736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/805736
Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury Mar 21, 2004 Issued
Array ( [id] => 7410484 [patent_doc_number] => 20040176373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Novel method of treatment' [patent_app_type] => new [patent_app_number] => 10/803300 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3506 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176373.pdf [firstpage_image] =>[orig_patent_app_number] => 10803300 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/803300
Novel method of treatment Mar 17, 2004 Abandoned
Array ( [id] => 7250144 [patent_doc_number] => 20040258774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of a 5-phosphodiaesterase inhibitor for the treatment of female sexual dysfunction' [patent_app_type] => new [patent_app_number] => 10/803148 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 777 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258774.pdf [firstpage_image] =>[orig_patent_app_number] => 10803148 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/803148
Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of a 5-phosphodiaesterase inhibitor for the treatment of female sexual dysfunction Mar 16, 2004 Abandoned
Array ( [id] => 7411015 [patent_doc_number] => 20040176420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Treatment of diabetes with thiazolidinedione and sulphonylurea' [patent_app_type] => new [patent_app_number] => 10/800579 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3484 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176420.pdf [firstpage_image] =>[orig_patent_app_number] => 10800579 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/800579
Treatment of diabetes with thiazolidinedione and sulphonylurea Mar 14, 2004 Abandoned
Array ( [id] => 7265135 [patent_doc_number] => 20040242671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug' [patent_app_type] => new [patent_app_number] => 10/489660 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9468 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242671.pdf [firstpage_image] =>[orig_patent_app_number] => 10489660 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/489660
Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug Mar 14, 2004 Abandoned
Array ( [id] => 7468927 [patent_doc_number] => 20040167172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Combination therapy for type II diabetes or syndrome X' [patent_app_type] => new [patent_app_number] => 10/790444 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7088 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 671 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167172.pdf [firstpage_image] =>[orig_patent_app_number] => 10790444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/790444
Combination therapy for type II diabetes or syndrome X Feb 29, 2004 Abandoned
Array ( [id] => 5149454 [patent_doc_number] => 20070049514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Resonance modulator for diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 10/547223 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18356 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049514.pdf [firstpage_image] =>[orig_patent_app_number] => 10547223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547223
Resonance modulator for diagnosis and therapy Feb 26, 2004 Abandoned
Array ( [id] => 7345205 [patent_doc_number] => 20040247552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least acid and at least one polyol ester' [patent_app_type] => new [patent_app_number] => 10/784948 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14282 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247552.pdf [firstpage_image] =>[orig_patent_app_number] => 10784948 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/784948
Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least acid and at least one polyol ester Feb 24, 2004 Abandoned
Array ( [id] => 7427943 [patent_doc_number] => 20040229934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method of reducing type 2 diabetes in high risk patients' [patent_app_type] => new [patent_app_number] => 10/783615 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3587 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229934.pdf [firstpage_image] =>[orig_patent_app_number] => 10783615 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/783615
Method of reducing type 2 diabetes in high risk patients Feb 19, 2004 Abandoned
Array ( [id] => 123161 [patent_doc_number] => 07705016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus' [patent_app_type] => utility [patent_app_number] => 10/545056 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21445 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705016.pdf [firstpage_image] =>[orig_patent_app_number] => 10545056 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545056
Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus Feb 11, 2004 Issued
Array ( [id] => 4543642 [patent_doc_number] => 07959946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative' [patent_app_type] => utility [patent_app_number] => 10/777542 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8342 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/959/07959946.pdf [firstpage_image] =>[orig_patent_app_number] => 10777542 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777542
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Feb 11, 2004 Issued
Array ( [id] => 7034303 [patent_doc_number] => 20050032813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria' [patent_app_type] => utility [patent_app_number] => 10/767705 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3671 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032813.pdf [firstpage_image] =>[orig_patent_app_number] => 10767705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/767705
Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria Jan 28, 2004 Abandoned
Array ( [id] => 7004665 [patent_doc_number] => 20050169978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Wet-micro grinding' [patent_app_type] => utility [patent_app_number] => 10/769118 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2971 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169978.pdf [firstpage_image] =>[orig_patent_app_number] => 10769118 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/769118
Wet-micro grinding Jan 28, 2004 Abandoned
Array ( [id] => 7462596 [patent_doc_number] => 20040166162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid' [patent_app_type] => new [patent_app_number] => 10/761805 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8342 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166162.pdf [firstpage_image] =>[orig_patent_app_number] => 10761805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/761805
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid Jan 20, 2004 Abandoned
Array ( [id] => 7425040 [patent_doc_number] => 20040208922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Method for loading lipid like vesicles with drugs or other chemicals' [patent_app_type] => new [patent_app_number] => 10/759222 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6813 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208922.pdf [firstpage_image] =>[orig_patent_app_number] => 10759222 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/759222
Method for loading lipid like vesicles with drugs or other chemicals Jan 19, 2004 Abandoned
Array ( [id] => 7419327 [patent_doc_number] => 20040228888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Cosmetic or dermatological formulations of improved pearlescence' [patent_app_type] => new [patent_app_number] => 10/759254 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15415 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228888.pdf [firstpage_image] =>[orig_patent_app_number] => 10759254 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/759254
Cosmetic or dermatological formulations of improved pearlescence Jan 19, 2004 Issued
Array ( [id] => 5620041 [patent_doc_number] => 20060189575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels' [patent_app_type] => utility [patent_app_number] => 10/542845 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8713 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189575.pdf [firstpage_image] =>[orig_patent_app_number] => 10542845 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/542845
Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels Jan 19, 2004 Issued
Menu